Hologic Management
Management criteria checks 3/4
Hologic's CEO is Steve MacMillan, appointed in Dec 2013, has a tenure of 11.17 years. total yearly compensation is $15.82M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.54% of the company’s shares, worth $88.98M. The average tenure of the management team and the board of directors is 1.8 years and 8 years respectively.
Key information
Steve MacMillan
Chief executive officer
US$15.8m
Total compensation
| CEO salary percentage | 7.7% |
| CEO tenure | 11.2yrs |
| CEO ownership | 0.5% |
| Management average tenure | 1.8yrs |
| Board average tenure | 8yrs |
Recent management updates
Recent updates
Is Hologic (NASDAQ:HOLX) A Risky Investment?
Jan 31
Hologic: Reasonably, But Not Compellingly Valued
Jan 17Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return
Jan 13Earnings Not Telling The Story For Hologic, Inc. (NASDAQ:HOLX)
Dec 22Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 60% Above Its Share Price
Dec 04When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?
Nov 02Hologic: Continued Room Amidst Bolt-On M&A Efforts
Oct 28Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly
Oct 17Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward
Sep 16Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar
Sep 01Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them
Aug 27Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?
Jul 21These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well
Jun 20Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down
May 22Hologic: Women's Health Play Looks Healthier Itself
May 13Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult
Apr 19Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)
Apr 05Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet
Mar 20Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching
Feb 22Hologic: Prospects For Growth As Headwinds Disappear
Feb 11We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings
Feb 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 28 2024 | n/a | n/a | US$744m |
| Sep 28 2024 | US$16m | US$1m | US$790m |
| Jun 29 2024 | n/a | n/a | US$702m |
| Mar 30 2024 | n/a | n/a | US$467m |
| Dec 30 2023 | n/a | n/a | US$515m |
| Sep 30 2023 | US$16m | US$1m | US$456m |
| Jul 01 2023 | n/a | n/a | US$484m |
| Apr 01 2023 | n/a | n/a | US$753m |
| Dec 31 2022 | n/a | n/a | US$990m |
| Sep 24 2022 | US$14m | US$1m | US$1b |
| Jun 25 2022 | n/a | n/a | US$2b |
| Mar 26 2022 | n/a | n/a | US$2b |
| Dec 25 2021 | n/a | n/a | US$2b |
| Sep 25 2021 | US$15m | US$1m | US$2b |
| Jun 26 2021 | n/a | n/a | US$2b |
| Mar 27 2021 | n/a | n/a | US$2b |
| Dec 26 2020 | n/a | n/a | US$1b |
| Sep 26 2020 | US$14m | US$1m | US$1b |
| Jun 27 2020 | n/a | n/a | US$497m |
| Mar 28 2020 | n/a | n/a | US$453m |
| Dec 28 2019 | n/a | n/a | US$84m |
| Sep 28 2019 | US$12m | US$1m | -US$204m |
| Jun 29 2019 | n/a | n/a | -US$30m |
| Mar 30 2019 | n/a | n/a | -US$11m |
| Dec 29 2018 | n/a | n/a | -US$419m |
| Sep 29 2018 | US$42m | US$1m | -US$111m |
Compensation vs Market: Steve's total compensation ($USD15.82M) is about average for companies of similar size in the US market ($USD12.46M).
Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.
CEO
Steve MacMillan (60 yo)
11.2yrs
Tenure
US$15,819,261
Compensation
Mr. Stephen P. MacMillan, also known as Steve, serves as an Independent Chairman of the Board at Illumina, Inc. from June 02, 2023. He has been the Chairman of the Board at Hologic Inc. since June 17, 2015...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11.2yrs | US$15.82m | 0.54% $ 89.0m | |
| Chief Financial Officer | 6.5yrs | US$4.09m | 0.0091% $ 1.5m | |
| Chief Operating Officer | 1.1yrs | US$4.08m | 0.0044% $ 723.0k | |
| General Counsel | 10yrs | US$3.47m | 0.034% $ 5.5m | |
| Group President of International | no data | US$3.59m | 0.040% $ 6.6m | |
| Chief Information Officer | 3.6yrs | no data | no data | |
| Corporate Vice President of Investor Relations | less than a year | no data | no data | |
| Senior Vice President of Global Human Resources | less than a year | no data | no data | |
| VP & Chief of Staff | 11.1yrs | no data | no data | |
| Division President of Diagnostic Solutions | 1.8yrs | no data | 0.0054% $ 880.8k | |
| Senior Vice President of Global Supply Chain | 1.3yrs | no data | no data | |
| Division President of GYN Surgical Solutions | 1.1yrs | no data | 0.0027% $ 448.6k |
1.8yrs
Average Tenure
56yo
Average Age
Experienced Management: HOLX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11.2yrs | US$15.82m | 0.54% $ 89.0m | |
| Independent Director | 11.8yrs | US$349.95k | 0.019% $ 3.1m | |
| Independent Director | 17.3yrs | US$357.45k | 0.058% $ 9.6m | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 2.1yrs | US$329.95k | 0.000070% $ 11.5k | |
| Independent Director | 6.3yrs | US$329.95k | 0.0026% $ 424.0k | |
| Independent Director | 7.8yrs | US$354.95k | 0.0068% $ 1.1m | |
| Independent Director | 13.3yrs | US$329.95k | 0.019% $ 3.2m | |
| Lead Independent Director | 8.2yrs | US$357.45k | 0.0085% $ 1.4m | |
| Independent Director | 1.4yrs | US$329.95k | 0.00033% $ 54.2k |
8.0yrs
Average Tenure
62yo
Average Age
Experienced Board: HOLX's board of directors are considered experienced (8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 23:56 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/12/28 |
| Annual Earnings | 2024/09/28 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hologic, Inc. is covered by 51 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Charles Butler | Barclays |